The epidemiology of acquired demyelinating syndrome in children: a complex opportunity to investigate the etiopathogenesis of multiple sclerosis

Affiliations

Comment

Maura Pugliatti et al. Dev Med Child Neurol. 2022 Apr.

. 2022 Apr;64(4):409-410.

doi: 10.1111/dmcn.15119. Epub 2021 Dec 14.

¹ Department of Neuroscience and Rehabilitation, University of Ferrara, Ferrara, Italy.

Abstract

This commentary is on the original article by Abdel‐Mannan et al. on pages 502–508 of this issue.

Incidence of paediatric multiple sclerosis and other acquired demyelinating syndromes: 10-year follow-up surveillance study.
Abdel-Mannan O, Absoud M, Benetou C, Hickson H, Hemingway C, Lim M, Wright S, Hacohen Y, Wassmer E; UK Childhood Neuroinflammatory Disorders Network. Abdel-Mannan O, et al. Dev Med Child Neurol. 2022 Apr;64(4):502-508. doi: 10.1111/dmcn.15098. Epub 2021 Oct 24. Dev Med Child Neurol. 2022. PMID: 34693523 Free PMC article.

1. Waubant E, Ponsonby A‐L, Pugliatti M, et al. Environmental and genetic factors in pediatric inflammatory demyelinating diseases. Neurology 2016; 87(9 Suppl 2): S20–7. - PubMed
1. Jeong A, Oleske DM, Holman J. Epidemiology of Pediatric‐Onset Multiple Sclerosis: A Systematic Review of the Literature. J Child Neurol 2019; 34: 705–12. - PubMed
1. Abdel‐Mannan, Absoud M , Benetou C, et al. Incidence of paediatric multiple sclerosis and other relapsing demyelination conditions: 10‐year follow‐up UK surveillance study. Dev Med Child Neurol 2022; 64: 502–8. - PubMed
1. Eusebi A, Zara P, Zarbo IR, et al. Long‐term trajectory of acquired demyelinating syndrome and multiple sclerosis in children. Dev Med Child Neurol 2021; 63: 1059–65. - PubMed
1. Fadda G, Brown RA, Longoni G, et al. MRI and laboratory features and the performance of international criteria in the diagnosis of multiple sclerosis in children and adolescents: a prospective cohort study. Lancet Child Adolesc Health 2018; 2: 191–204. - PubMed